A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
Abroad (travel likely)RecruitingPHASE1
Conditions
Diffuse Large B Cell Lymphoma Refractory · Diffuse Large B Cell Lymphoma Relapsed · Epstein-Barr Virus (EBV) Infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Kentucky, Lexington, Kentucky, United States
Contact: Study coordinator (Pierluigi Porcu)
Study leads
Pierluigi Porcu, MD
Principal Investigator
University of Kentucky